Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-233

Agree, it would certainly take days for full effect.
* It took 3-4 days for share price reaching its highest (from $0.135 to $0.175) after Antimicrobial Data Published in UQ and Peer-Reviewed Journal.
* The short sellers would try to recover the remaining 3 millions short selling in the lower prices.
* Vine would have presented those Top-Line Data of BTX 1801 2a Clinical Study Results with Big Pharma (eg Pfizer etc). Watch this space for TO.
* Professor Geoffrey Coombs, Murdoch University’s Chair of Public Health, commented: "Data from the BTX 1801 study represents a significant milestone and enhances the potential of better infection prevention measuresin surgical settings to combat the growing global development of antibiotic resistance"
* The UN forecasting that drug resistant diseases could cause 10 million deaths each year by 2050 and result in an annual economic loss of US$100 trillion if new solutions are not found.